TELIGEN
Report
- Report Number
- 2124215-2014-12650
- Event Type
- Injury
- Date Received
- July 9, 2014
- Date of Event
- May 5, 2014
- Report Date
- November 25, 2014
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWP
- PMA / PMN Number
- P960040
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- VA
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). THE PRODUCT HAS BEEN RECEIVED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON COMPLETION OF ANALYSIS.
(B)(4). THE RETURN OF THE PRODUCT WAS REQUESTED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
(B)(4). ADDITIONAL INFORMATION WAS RECEIVED THAT THE PRODUCT IS IN POSSESSION OF THE HOSPITAL AND IS NOT EXPECTED TO BE RETURNED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
(B)(4). AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
(B)(4). UPON RECEIPT IN OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION NOTED THAT THE HEADER WAS LOOSE. X-RAY EXAMINATION WAS PERFORMED. THE RV TIP AND RV RING HEADER WIRE(S) WERE FOUND TO BE FRACTURED. IMPROVEMENTS HAVE BEEN MADE TO THE MANUFACTURING PROCESS IN ORDER TO STRENGTHEN THE BOND BETWEEN THE HEADER AND THE DEVICE CASE. LABORATORY ANALYSIS CONFIRMED THE REPORTED CLINICAL OBSERVATIONS.
ADDITIONAL INFORMATION WAS RECEIVED THAT THIS ICD AND RV LEAD WERE EXPLANTED FOUR MONTHS LATER. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECEIVED AN INAPPROPRIATE SHOCK DUE TO A COMPROMISED RIGHT VENTRICULAR (RV) LEAD. THIS ICD AND RV LEAD EXHIBITED HIGH, OUT-OF-RANGE (OOR) PACING LEAD IMPEDANCE MEASUREMENT GREATER THAN 2,000 OHMS ALONG WITH OVERSENSING OF NOISE AND LOSS OF CAPTURE (LOC). SUBSEQUENTLY, THE DEVICE WAS PROGRAMMED TO MONITOR ONLY AND AN ALERT FOR OUT-OF-RANGE PACING LEAD IMPEDANCE WAS THEN DETECTED VIA THE PATIENT¿S REMOTE MONITORING SYSTEM. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT LOC DID NOT RESULT TO GREATER THAN 2 SECONDS OF ASYSTOLE AND SURGICAL INTERVENTION HAS NOT BEEN PERFORMED. A WEEK LATER, A RED ALERT FOR THE HIGH, OOR, SHOCK IMPEDANCE MEASUREMENT WAS DETECTED. AT THIS TIME, THE SYSTEM REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 400512 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWP | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 59 YR | Hospitalization| L| R | 5076| 0157| E110| A135 |